BRAIN BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.260 EUR | +0.62% |
|
-1.51% | -8.17% |
| Jan. 14 | BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024 | CI |
| Dec. 12 | BRAIN Biotech AG - Analyst/Investor Day |
Evolution of the Average Target: BRAIN Biotech AG
Evolution of the Target Price: BRAIN Biotech AG
Changes in Analyst Recommendations: BRAIN Biotech AG
ba.IYZz4-TPC8sXv1QCpDNntqTAg7aNEsIDmwl_FV0Qug0.RdEdsbC_YpFO_m1U8gNe28vx0NvLJYRkzV81YmQl4HdNtB3Rk61Su0DtEQ~0c342169d482ffd8a7e765bbb00fd0a2
| Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +103.60% | ||||||
| +174.86% | ||||||
| Average | +139.23% | |||||
| Weighted average by Cap. | +152.13% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.260EUR
Average target price
6.638EUR
Spread / Average Target
+103.60%
High Price Target
10.00EUR
Spread / Highest target
+206.75%
Low Price Target
5.100EUR
Spread / Lowest Target
+56.44%
Analyst Consensus Detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- BNN Stock
- Consensus BRAIN Biotech AG